Mackenzie Financial
NUVB icon

Mackenzie Financial’s Nuvation Bio NUVB Stock Holding History

Mackenzie Financial’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,746
Closed -$140K – 1650
2025
Q4 		$140K Hold
15,746
– – ﹤0.01% 1571
2025
Q3 		$58.3K Buy
15,746
+4,400
+39% +$12K ﹤0.01% 1652
2025
Q2 		$22.1K Hold
11,346
– – ﹤0.01% 1675
2025
Q1 		$20K Hold
11,346
– – ﹤0.01% 1649
2024
Q4 		$30.2K Hold
11,346
– – ﹤0.01% 1675
2024
Q3 		$26K Buy
+11,346
New +$34.6K ﹤0.01% 1561

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mackenzie Financial's NUVB Position: Q1 2026 in Review

Mackenzie Financial sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 15,746 shares — an estimated $140K sold.

Mackenzie Financial first reported a position in NUVB in Q3 2024 and held it in 6 quarters. The position peaked at $140K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Mackenzie Financial reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
  • Mackenzie Financial sold 15,746 Nuvation Bio shares in Q1 2026, an estimated $140K.
  • Mackenzie Financial first reported a position in Nuvation Bio in Q3 2024 and held it in 6 quarters.
  • Mackenzie Financial's Nuvation Bio position peaked at $140K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.